- Nachrichtendetail
-
13.05.2024 12:50:41 - dpa-AFX: *MERCK ANNOUNCES DISCONTINUATION OF VIBOSTOLIMAB AND PEMBROLIZUMAB COFORMULATION ARM OF PHASE 3 KEYVIBE-010 TRIAL
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
MERCK CO. DL-,01 | A0YD8Q | Xetra | 124,400 | 25.06.24 15:16:01 | +1,200 | +0,97% | 124,000 | 124,600 | 123,800 | 123,200 |
